Purpose/Hypothesis: Parkinson’s disease (PD) is a progressive, neurodegenerative disorder characterized by both motor and non ...

The most common prodromal symptom of Parkinson disease among community-dwelling older adults was cognitive deficit, followed by subthreshold parkinsonism, urinary dysfunction, and olfactory ...

This week Bobbi Conner talks with Dr. Scott Hutchison about oncology occupational therapy. Dr. Hutchison is a Doctor of ...

The longstanding partnership between The Michael J. Fox Foundation for Parkinson's Research (MJFF) and the Edmond J. Safra Foundation continues to open the door toward scientific advances and ...

The service, based in north central Florida and led by an occupational therapist, fills a gap for children with disabilities ...

Mental health patients in Hartlepool have been reaping the benefits of a therapeutic garden space they began transforming ...

As an occupational therapist, we evaluate and we treat clients based on those disabilities or those injuries that they have.

Please provide your email address to receive an email when new articles are posted on . In this video, Andres Deik, MD, MSEd, FAAN, discusses the results of the ROSSINI study, presented at the 2025 ...

Australian-founded medical technology company SYMBYX today announced compelling results from a 72-week randomized controlled trial (RCT) demonstrating improvements in a range of Parkinson's disease ...

The MarketWatch News Department was not involved in the creation of this content. SHANGHAI, Oct. 16, 2025 /PRNewswire/ -- Unixell Biotech, a clinical-stage bitotech company focused on developing ...

SHANGHAI, Oct. 16, 2025 /PRNewswire/ -- Unixell Biotech, a clinical-stage bitotech company focused on developing innovative cell therapies for Parkinson's disease (PD) and other neurological disorders ...

These long-term findings in a large patient cohort show the sustained clinical efficacy and safety of autologous CD34+ hematopoietic stem-cell lentiviral gene therapy for ADA-SCID, indicating that it ...